Shares of The Joint Corp. (NASDAQ:JYNT - Get Free Report) passed below its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of $10.62 and traded as low as $10.02. Joint shares last traded at $10.10, with a volume of 36,433 shares.
Analysts Set New Price Targets
Several equities analysts have commented on JYNT shares. Wall Street Zen cut shares of Joint from a "buy" rating to a "hold" rating in a research note on Monday, March 17th. Lake Street Capital decreased their target price on shares of Joint from $20.00 to $16.00 and set a "buy" rating for the company in a report on Friday, May 9th.
Read Our Latest Stock Report on JYNT
Joint Price Performance
The firm has a market capitalization of $160.99 million, a price-to-earnings ratio of -9.23 and a beta of 1.54. The firm's fifty day moving average is $10.48 and its 200 day moving average is $10.91.
Joint (NASDAQ:JYNT - Get Free Report) last issued its quarterly earnings data on Thursday, May 8th. The company reported ($0.03) earnings per share for the quarter, missing the consensus estimate of ($0.02) by ($0.01). The business had revenue of $13.08 million for the quarter, compared to the consensus estimate of $13.02 million. Joint had a negative net margin of 13.95% and a positive return on equity of 8.24%. Equities research analysts forecast that The Joint Corp. will post 0.11 EPS for the current fiscal year.
Hedge Funds Weigh In On Joint
Institutional investors have recently modified their holdings of the company. BNP Paribas Financial Markets increased its position in Joint by 6.8% during the fourth quarter. BNP Paribas Financial Markets now owns 24,031 shares of the company's stock worth $255,000 after acquiring an additional 1,521 shares during the period. Geode Capital Management LLC boosted its stake in Joint by 0.5% during the fourth quarter. Geode Capital Management LLC now owns 293,133 shares of the company's stock worth $3,116,000 after buying an additional 1,552 shares in the last quarter. Wells Fargo & Company MN boosted its stake in shares of Joint by 51.7% in the 4th quarter. Wells Fargo & Company MN now owns 5,088 shares of the company's stock valued at $54,000 after purchasing an additional 1,735 shares in the last quarter. Barclays PLC boosted its stake in shares of Joint by 6.9% in the 4th quarter. Barclays PLC now owns 27,380 shares of the company's stock valued at $291,000 after purchasing an additional 1,771 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its stake in shares of Joint by 9.1% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 36,204 shares of the company's stock valued at $385,000 after purchasing an additional 3,029 shares in the last quarter. Institutional investors own 76.88% of the company's stock.
About Joint
(
Get Free Report)
The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.
Featured Articles
Before you consider Joint, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Joint wasn't on the list.
While Joint currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
